PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival
2025 · Journal of Thoracic Oncology · 7 citations
https://doi.org/10.1016/j.jtho.2025.09.015
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
95
Citations
6
h-index
2
i10-index
Y. Liu is an academic researcher from Xuzhou Medical College. The author has contributed to research in topics: Gout, Hyperuricemia, Uric Acid & Lung Cancer Treatments and Mutations & Lung Cancer Research Studies. The author has an h-index of 6, co-authored 28 publications.
ORCID: 0000-0001-6985-1434https://doi.org/10.1016/j.jtho.2025.09.015
https://doi.org/10.1186/s13018-023-03847-w
https://doi.org/10.1186/s13020-025-01193-z
https://doi.org/10.1186/s12891-024-07570-3
Click to start Chat